✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Vivo Bio Tech Ltd.

VIVOBIOT

Market Cap
₹71 Cr.
P/E
10.26

Vivo Bio Tech Ltd.

  • Vivo Bio Tech
  • Jeevan Scientific
  • Zenotech Laboratorie
FAQs on Vivo Bio Tech Ltd. Shareprice

Vivo Bio Tech has given lower returns compared to its competitors.
Vivo Bio Tech has grown at ~-5.66% over the last 7yrs while peers have grown at a median rate of 1.39%

Vivo Bio Tech is not expensive.
Latest PE of Vivo Bio Tech is 10.26, while 3 year average PE is 19.55.
Also latest EV/EBITDA of Vivo Bio Tech is 6.11 while 3yr average is 6.34.

View FAQ's On Business
Growth Table
  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie
Balance Sheet
  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie
Cash Flow
  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie
Quarterly Results
  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Vivo Bio Tech Ltd. Financials

Vivo Bio Tech balance sheet is weak and might have solvency issues

The debt of Vivo Bio Tech is decreasing.
Latest debt of Vivo Bio Tech is ₹56.51 Crs as of Sep-24.
This is less than Mar-24 when it was ₹70.53 Crs.

The profit is oscillating.
The profit of Vivo Bio Tech is ₹6.96 Crs for TTM, ₹2.53 Crs for Mar 2024 and ₹2.65 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vivo Bio Tech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech